Search
for
Sort by
Research 91–120 of 513
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- New drugs under investigation for the treatment of alopecias
- Lichen Planopilaris
- Hair: What is New in Diagnosis and Management?
- Novel therapies for alopecia areata: The era of rational drug development
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Ultraviolet B Preconditioning Enhances the Hair Growth-Promoting Effects of Adipose-Derived Stem Cells Via Generation of Reactive Oxygen Species
- The Editor's Choice
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Cyclin-dependent kinase inhibitors, p21waf1/cip1 and p27kip1, are expressed site- and hair cycle-dependently in rat hair follicles
- Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients